Concepedia

Kristina Gutschmidt

KG

Statistics

Publications

4

Citations

211

H-Index

4

Active since

2021

Affiliations

Ludwig-Maximilians-Universität München(Current)

University of Messina

Hospital de Sant Pau

Kristina Gutschmidt is an author at Ludwig-Maximilians-Universität München specializing in clinical trials, pharmacotherapy, and medicine.

Top concepts

Publications per year

2021–2021

4

Publications

4

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

Benedikt Schoser, Mark Roberts, Barry J. Byrne et al. · The Lancet Neurology · 2021 · 124 citations

, , +2

STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa

Kristina Gutschmidt, Olimpia Musumeci, Jordi Díaz‐Manera et al. · Journal of Neurology · 2021 · 55 citations · Full text

Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1

Stephan Wenninger, Sarah A. Cumming, Kristina Gutschmidt et al. · Neurology Genetics · 2021 · 20 citations · Full text

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease

Stephan Wenninger, Kristina Gutschmidt, Corinna Wirner et al. · Journal of Neurology · 2021 · 12 citations · Full text

1–4 of 4